Update: Elan's Tysabri Risk
- Length: 2:27
- Rating Average: n/a
- View Count: 143
- Author: Bloomberg
Tags: bloomberg Business Commerce Finance Issues Law Legal NASDAQ:BIIB News NYSE:ELN Personal Science Shopping Technology television tv
Elan Rises on Revisions to Tysabri Drug Label
Healthcare Stocks to Watch: Johnson & Johnson, Genentech, Wyeth
- Length: 2:57
- Rating Average: n/a
- View Count: 221' favoriteCount='1
- Author: Bloomberg
Tags: bloomberg Business Commerce Finance Health Issues Law Legal NASDAQ:BIIB NASDAQ:OSIB News NYSE:ABT NYSE:DNA NYSE:JNJ NYSE:KG NYSE:PG NYSE:WPI NYSE:WYE OTC:RHHBY Personal Science Shopping Technology television tv
Both J&J and Genentech Boost 2008 Profit Outlooks; Johnson & Johnson 2Q U.S. Sales Up 2%, Global Sales Up 16%; Genentech Best Biotech Performer Today, Avastin Sales Up 15% and Rituxan Sales Up 12%; Wyeth Buys Procter & Gamble's ThermaCare Unit
Page: 1 of 1
